Current Edition

ICON

ICON announces agreement with Intel allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it …

Continue Reading →